Probi AB (publ) (PBBIF)
PBBIF Stock Price Chart
Explore Probi AB (publ) interactive price chart. Choose custom timeframes to analyze PBBIF price movements and trends.
PBBIF Company Profile
Discover essential business fundamentals and corporate details for Probi AB (publ) (PBBIF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Oct 2016
Employees
157.00
Website
https://www.probi.comCEO
Anita Johansen
Description
Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian women. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.
PBBIF Financial Timeline
Browse a chronological timeline of Probi AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 22 Oct 2024
EPS came in at $0.03 , while revenue for the quarter reached $14.08M , missing expectations by -11.51%.
Earnings released on 16 Jul 2024
EPS came in at $0.07 , while revenue for the quarter reached $16.88M , beating expectations by +3.92%.
Earnings released on 23 Apr 2024
EPS came in at $0.02 , while revenue for the quarter reached $14.17M , missing expectations by -12.88%.
Earnings released on 26 Jan 2024
EPS came in at -$0.02 , while revenue for the quarter reached $15.41M , beating expectations by +0.27%.
Dividend declared on 26 Jan 2024
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 15 May 2024.
Earnings released on 29 Sept 2023
EPS came in at $0.05 , while revenue for the quarter reached $14.23M , beating expectations by +8.35%.
Earnings released on 29 Jun 2023
EPS came in at -$0.05 , while revenue for the quarter reached $13.27M , missing expectations by -7.28%.
Dividend declared on 3 Apr 2023
A dividend of $0.13 per share was announced, adjusted to $0.13. The dividend was paid on 11 May 2023.
Earnings released on 30 Mar 2023
EPS came in at $0.16 , while revenue for the quarter reached $16.48M , beating expectations by +12.30%.
Earnings released on 27 Jan 2023
EPS came in at -$0.50 falling short of the estimated $1.89 by -126.46%, while revenue for the quarter reached $13.75M , missing expectations by -15.80%.
Earnings released on 21 Oct 2022
EPS came in at $1.09 falling short of the estimated $2.13 by -48.83%, while revenue for the quarter reached $13.01M , missing expectations by -16.14%.
Earnings released on 15 Jul 2022
EPS came in at $1.75 surpassing the estimated $1.58 by +10.76%, while revenue for the quarter reached $17.00M , missing expectations by -1.41%.
Earnings released on 26 Apr 2022
EPS came in at $1.23 falling short of the estimated $2.31 by -46.75%, while revenue for the quarter reached $16.46M , missing expectations by -14.36%.
Earnings released on 2 Feb 2022
EPS came in at $2.31 surpassing the estimated $2.29 by +0.87%, while revenue for the quarter reached $18.72M , missing expectations by -8.11%.
Dividend declared on 2 Feb 2022
A dividend of $0.13 per share was announced, adjusted to $0.13. The dividend was paid on 12 May 2022.
Earnings released on 22 Oct 2021
EPS came in at $1.62 falling short of the estimated $2.23 by -27.35%.
Earnings released on 16 Jul 2021
EPS came in at $1.39 falling short of the estimated $2.43 by -42.80%.
Earnings released on 23 Apr 2021
EPS came in at $1.99 falling short of the estimated $2.04 by -2.45%.
Earnings released on 9 Feb 2021
EPS came in at $1.92 falling short of the estimated $2.43 by -20.99%.
Dividend declared on 9 Feb 2021
A dividend of $0.13 per share was announced, adjusted to $0.13. The dividend was paid on 17 May 2021.
Earnings released on 21 Oct 2020
EPS came in at $2.91 surpassing the estimated $2.12 by +37.26%.
PBBIF Stock Performance
Access detailed PBBIF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.